Patent · US Active

(Heterocycle/tetrahydropyridine)-(piperazinyl)-1-alcanone and (heterocycle/dihydropyrrolidine)-(piperazinyl)-1-alcanone derivatives, and use thereof as p75 inhibitors

US8518947B2 · kind B2 · utility

2Cited by

5References

14Claims

0Family size

Assignee

Sanofi · FR

Inventors

Marco Baroni · Mantova, IT
Francoise Bono · Paris, FR
Sandrine Delbary-Gossart · Mauzac, FR
Valentina Vercesi · Pavia, IT

Key dates

Filing date	Jun 7, 2012
Grant date	Aug 27, 2013
Priority date	—
Expiry date	Jun 7, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D495/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The disclosure relates to (heterocycle-tetrahydropyridine)(piperazinyl)-1-alkanone and (heterocycle-dihydropyrrolidine)(piperazinyl)-1-alkanone derivatives of formula (I):wherein A, B, m, n, W, and R2 are as defined in the disclosure; to the methods of preparing said derivatives, and to the therapeutic uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.